H3.3 G34R Mutations In Pediatric Primitive Neuroectodermal Tumors ...

Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search: Search Advanced Clipboard Save Email Send to

• Clipboard
• My Bibliography
• Collections
• Citation manager

Display options Display options Format Abstract PubMed PMID

Save citation to file

Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel

Email citation

Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel

Add to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error Please try again Add Cancel

Add to My Bibliography

• My Bibliography

Unable to load your delegates due to an error Please try again Add Cancel

Your saved search

Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons

• Yes
• No

Email: (change) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel

Create a file for external citation management software

Create file Cancel

Your RSS Feed

Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy

Full text links

Springer Full text links

Actions

CiteCollectionsAdd to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an errorPlease try again Add Cancel PermalinkPermalinkCopyDisplay options Display options Format AbstractPubMedPMID

Page navigation

• Title & authors
• Abstract
• References
• MeSH terms
• Substances
• LinkOut - more resources

Title & authors Abstract References MeSH terms Substances LinkOut - more resources Full text links CiteDisplay options Display options Format AbstractPubMedPMID

Abstract

Pediatric glioblastomas recently have been exon sequenced with evidence that approximately 30 % of cases harbour mutations of the histone H3.3 gene. Although studies to determinate their role in risk stratification are on-going, it remains to be determined whether H3.3 mutations could be found in other tumors such as pediatric primitive neuroectodermal tumors of the central nervous system (CNS-PNETs) and whether the presence of H3.3 mutations in glioblastomas could be used as diagnostic tool in their differential diagnosis with CNS-PNETs. We performed a large mutational pyrosequencing-based screening on 123 pediatric glioblastomas and 33 CNS-PNET. The analysis revealed that 39/123 (31.7 %) glioblastomas carry H3.3 mutations. The K27M (AAG → ATG, lysine → methionine) mutation was found in 33 glioblastomas (26 %); the G34R (GGG → AGG, glycine → arginine) was observed in 6 glioblastomas (5.5 %). However, we also identified 4 of 33 cases (11 %) of CNS-PNETs harbouring a H3.3 G34R mutation. Multiplex ligation-dependent probe amplification analysis revealed PDGFR-alpha amplification and EGFR gain in two cases and N-Myc amplification in one case of H3.3 G34R mutated CNS-PNET. None of H3.3 mutated tumors presented a CDKN2A loss. In conclusion, because pediatric patients with glioblastoma and CNS-PNET are treated according to different therapeutic protocols, these findings may raise further concerns about the reliability of the histological diagnosis in the case of an undifferentiated brain tumor harbouring G34R H3.3 mutation. In this view, additional studies are needed to determine whether H3.3 G34 mutated CNS-PNET/glioblastomas may represent a defined tumor subtype.

PubMed Disclaimer

References

1. 1. Oncologist. 2004;9(2):197-206 - PubMed
2. 1. Brain Pathol. 2006 Jan;16(1):86 - PubMed
3. 1. Diagn Mol Pathol. 2012 Dec;21(4):189-206 - PubMed
4. 1. Nat Rev Mol Cell Biol. 2009 Oct;10(10):697-708 - PubMed
5. 1. Brain Pathol. 2009 Jan;19(1):81-90 - PubMed

Show all 23 references

MeSH terms

• Adolescent Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Arginine / genetics Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Central Nervous System Neoplasms / genetics* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Central Nervous System Neoplasms / pathology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Child Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Child, Preschool Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• DNA Mutational Analysis Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Female Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Glioblastoma / genetics* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Glioblastoma / pathology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Glycine / genetics Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Histones / genetics* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Humans Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Male Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Mutation / genetics* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Neuroectodermal Tumors, Primitive / genetics* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Neuroectodermal Tumors, Primitive / pathology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Receptor, Platelet-Derived Growth Factor alpha / genetics Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Receptor, Platelet-Derived Growth Factor alpha / metabolism Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Substances

• Histones Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Arginine Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Receptor, Platelet-Derived Growth Factor alpha Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Glycine Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • scite Smart Citations

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal

Full text links [x] Springer [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To

• Clipboard
• Email
• Save
• My Bibliography
• Collections
• Citation Manager

[x]

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.